West Pharmaceutical Services, Inc.
WST
Rang in Aktien
#878
West Pharmaceutical Services, Inc. (WST) specializes in the development,... West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Aktienkurs
$389.10
Marktkapitalisierung
$27.38B
Veränderung (1 Tag)
1.30%
Veränderung (1 Jahr)
41.54%
Land
US
Handel West Pharmaceutical Services, Inc. (WST)
Kategorie
Healthcare
KGV für West Pharmaceutical Services, Inc. (WST)
KGV zum October 2026 TTM: 47.60
Laut den neuesten Finanzberichten und dem Aktienkurs von West Pharmaceutical Services, Inc. beträgt das aktuelle P/E-Verhältnis (TTM) 47.60. Am Ende des Jahres 2023 hatte das Unternehmen ein P/E von 44.09.
P/E-Verlaufsdaten für West Pharmaceutical Services, Inc. von 2000 bis 2026
P/E-Verhältnis am Ende jedes Jahres
| Jahr | KGV | ändert |
|---|---|---|
| 2026 (TTM) | 47.60 | -1.91% |
| 2024 | 48.53 | 10.08% |
| 2023 | 44.09 | 47.53% |
| 2022 | 29.89 | -43.32% |
| 2021 | 52.73 | -12.81% |
| 2020 | 60.48 | 31.40% |
| 2019 | 46.03 | 31.45% |
| 2018 | 35.01 | -27.64% |
| 2017 | 48.39 | 11.74% |
| 2016 | 43.30 | -4.53% |
| 2015 | 45.35 | 52.71% |
| 2014 | 29.70 | -2.33% |
| 2013 | 30.41 | 31.79% |
| 2012 | 23.07 | 36.16% |
| 2011 | 16.94 | -19.35% |
| 2010 | 21.01 | 18.63% |
| 2009 | 17.71 | 24.43% |
| 2008 | 14.23 | -24.20% |
| 2007 | 18.78 | -23.63% |
| 2006 | 24.59 | 43.98% |
| 2005 | 17.08 | -55.90% |
| 2004 | 38.72 | 151.44% |
| 2003 | 15.40 | -19.63% |
| 2002 | 19.16 | -126.13% |
| 2001 | -73.33 | -133.16% |
| 2000 | 221.15 | 0.00% |
P/E-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/E Ratio | P/E Ratio-Differenz | Land |
|---|---|---|---|
| 47.48 | -0.25% |
US
|
|
| 27.43 | -42.39% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 19.51% |
US
|
|
| - | - |
CH
|
Wie liest man ein P/E Ratio?
Das Kurs-Gewinn-Verhältnis (P/E Ratio) misst das Verhältnis zwischen dem Aktienkurs eines Unternehmens und seinem Gewinn pro Aktie.
Ein niedriges, aber positives P/E weist auf ein Unternehmen hin, das hohe Gewinne im Verhältnis zur aktuellen Bewertung erzielt und möglicherweise unterbewertet ist. Ein Unternehmen mit einem hohen negativen (nahe 0) P/E macht hohe Verluste im Verhältnis zur Bewertung.
Unternehmen mit einem P/E über 30 oder negativ werden allgemein als "Wachstumsaktien" betrachtet, was bedeutet, dass Investoren erwarten, dass das Unternehmen in Zukunft wächst oder profitabel wird.
Unternehmen mit einem positiven P/E unter 10 gelten im Allgemeinen als "Value-Aktien", was bedeutet, dass das Unternehmen bereits sehr profitabel ist, aber in Zukunft wahrscheinlich kein starkes Wachstum aufweisen wird.